Strong margins mask revenue stall; wealth pivot unproven

QoQ revenue -0.3% flat; Q2 early trends 'fairly flattish'; dependent on market volatility

W, MF Prime launched but metrics withheld as 'too early'; Fisdom+AMC <2% revenue; no AUM disclosed

CFO confirmed cash yields up roughly 5% YoY; expect 1-2% quarterly increases

Employee cost increase due to appraisal cycle not headcount; ESOP ~10% of costs; no crazy headcount growth expected

CEO stated >28% retail market share in notional ADTO

Bonds now launched & scaling; US stocks licensed (vs prior 'planned'); AMC got SEBI/CCI approval. But traction metrics remain withheld.

QoQ revenue -0.3% (flat); Q2 early trends 'fairly flattish' vs prior quarter's momentum. Management attributes to market volatility, not product issues.

OPM 64.7%, NPM 47.5% maintained despite revenue plateau. Cost discipline evident; ESOP ~10% of employee spend.

Increase due April appraisal cycle, not headcount. Expect tech/AI-driven wealth model; org count not to increase significantly.

Adoption pending; infra improvements expected to boost penetration. Cash yields up ~5% YoY; expect 1-2% gains quarterly.

Q4 exception due to volatility. Q1 vs Q3 shows improvement; stabilizing trend. ESOP ~10% of Q1 employee cost.

Testing mode; will launch soon but no exact timeline. Start with US, then assess demand for other geographies. Learning curve product.

No SEBI signal on new rules. Impact hard to pinpoint—multiple changes happened in parallel.

Bit too early. Process is 'build 10x product, go slow, then run fast.' More color in coming quarters.

All products at different life stages. Core business gets more efficient; new products from existing teams via pod structure. Confident in progress.

Bit early. Very confident and happy with progress seen; numbers in coming calls.

Nothing top of mind currently.

Market at Q-end bullish; now volatile. MTF correlated with volatility more than regulation. Q4 anomaly (negative close); Q1 positive close boosted number.

Q4 was volatility anomaly; Q1 better vs Q3. Comparison should exclude Q4. Adding ₹600–700 Cr MTF quarterly.

Hard to estimate. MTF strong but multiple variables (ticket size, rate changes). Near-term expect increases; long-term uncertain.

IPL in Q1 (2 months) vs Q4 (1 week). Branding benefit; not directly correlated to acquisition. Without IPL would be lower.

Won't disclose. Too much detail; INR5 minimum, MIS complexity. Average is what you work with.

No significant improvement yet. Still in gestation stage. Will talk when more relevant.

Slight improvement; Q4 had one-time risk costs. Expect continuation with slight inflationary increases.

Significantly better than peers; ~100%. AUM stickiness + long-term habit + quality base = very high retention.

FY26 acquisition quality better. ARPU improving as platform matures. Data still building; will share later.

Fixed pricing 14.95% charged on balance. Slight delta vs average due to timing; roughly 14.95%.

Product development (engineers use AI, build faster/parallel). Customer support (faster query resolution, context). UX edge cases (GR1 handles niche requests). Investing decision support.

Hard to predict 3–4 years. Current 1–2 year pipeline very strong: W (mammoth suite), Bonds (launched, scaling), US stocks (launching soon). Best products never done-done.

Good indication but numbers too nascent. Will share in coming calls.

Privacy important. Do things to help customers but careful about perception. Some data used for UX; may do more carefully.

Reaffirmed strategic shift to wealth mgmt but declined to provide revenue/margin/AUM targets. Vague on product-line guidance.

Q1 benefited from one-time Q4 costs; expect normalization + 1–2% annual inflation.

47.5% NPM and 64.7% OPM maintained despite revenue plateau; operational leverage from existing business.

Scale-up investments in wealth platforms (W, Prime) and new products (US stocks) expected; no quantum disclosed.

QoY revenue flat (-0.3%); Q2 early MTF trends weak. Volume-dependent on market volatility. If growth doesn't reaccelerate, margin leverage expires.

Company building W (wealth suite), Bonds (scaling), US stocks (testing), AMC (early), Fisdom (gestation) in parallel. Metrics withheld 'too early.' Risk of dilution, cost overruns, or missed timelines.

November 24 margin rule and potential June/July rule on expiry day margins. Iran war volatility impacting F&O volume. Data personalization limited by privacy concerns.

W, MF Prime, affluent/HNI targeting launched but no disclosed AUM, customer count, or retention metrics. Affluent retention ~100% claimed but cohort size unknown. Wealth is capital-light but unproven margin profile.

CAC jumped to ₹1,900 from ₹1,400 (prior Q1) and ₹1,000 (Q4). IPL sponsorship (2 months Q1 vs 1 week Q4) cited as driver. Branding benefit claimed but not directly correlated to acquisition volumes.